nfr-logonfr-logo
PROJECT BANK
Bytt til Norsk språk
Statistics
Projects

0 projects

Date from new to old

H20-HEALTH-Health, demographic change and wellbeing

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

Awarded: NOK 8.6 mill.

Project Period: 2020-2025

Location: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19

Funding of research and innovation programmes for the development of novel SARS-CoV-2 vaccine against COVID-19 disease The overall objective is to leverage co-funding from the European Commission to support CEPI’s COVID-19 vaccine programme development efforts. The COVID-19 outbreak has in a sho...

Awarded: NOK 1.1 bill.

Project Period: 2020-2022

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases

European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases

Awarded: NOK 11.5 mill.

Project Period: 2020-2025

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Beyond 1M Genomes

Beyond 1M Genomes

Awarded: NOK 0.24 mill.

Project Period: 2020-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA

Awarded: NOK 0.63 mill.

Project Period: 2020-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Rapid European SARS-CoV-2 Emergency research Response

RECoVER (Rapid European SARS-CoV-2 Emergency Research response) is a comprehensive research response to the SARS-CoV-2 outbreak addressing the most urgent questions for patient and public health level interventions. RECoVER originates from partners of the EU Framework 7 (FP7) funded PREPARE proje...

Awarded: NOK 0.67 mill.

Project Period: 2020-2022

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

MULTILEVEL INTERVENTIONS TO PROMOTE MENTAL HEALTH IN SMEs AND PUBLIC WORKPLACES

Recent reports indicate an increase in mental health problems among the general EU population in recent years. Small and Medium-sized Enterprises (SMEs) and public organisations are particularly vulnerable as they have often scarce knowledge and resources to effectively manage workers’ mental he...

Awarded: NOK 4.3 mill.

Project Period: 2020-2023

Location: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.

A novel Stratified Medicine Algorithm to predict treatment responses to host-directed therapy in TB patients.

Awarded: NOK 8.3 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Prevention and Remediation of Insulin Multimorbidity in Europe

Prevention and Remediation of Insulin Multimorbidity in Europe

Awarded: NOK 3.4 mill.

Project Period: 2020-2024

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.

RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.

Awarded: NOK 18.4 mill.

Project Period: 2020-2024

Location: Oslo og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Impact of exposome on the course of lung diseases

Impact of exposome on the course of lung diseases

Awarded: NOK 3.4 mill.

Project Period: 2020-2024

Location: Troms - Romsa - Tromssa

H20-HEALTH-Health, demographic change and wellbeing

PERsonalised MedicIne Trials

Scientific excellence, and acceptance by health authorities of results derived from research on personalised medicine require standards ensuring validity and reproducibility. The objective of PERMIT is to establish, with all relevant stakeholders and invited experts, recommendations ensuring the ...

Awarded: Hidden

Project Period: 2020-2021

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Human Exposomic Determinants of Immune Mediated Diseases

Human Exposomic Determinants of Immune Mediated Diseases

Awarded: NOK 6.3 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity

Molecular Mechanisms Associating Chronic Pain with Fatigue, Affective Disorders, Cardiovascular Disease and Total Comorbidity

Awarded: NOK 21.2 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Exposome project for health and occupational research

Exposome project for health and occupational research

Awarded: NOK 9.7 mill.

Project Period: 2020-2024

Location: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases

Dynamic longitudinal exposome trajectories in cardiovascular and metabolic non-communicable diseases

Awarded: NOK 4.9 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Advancing Tools for Human Early Lifecourse Exposome Research and Translation

ATHLETE aims to develop a toolbox of advanced, next-generation, exposome tools and a prospective exposome cohort, which will be used to systematically quantify the effects of a wide range of community-level and individual-level environmental risk factors on mental, cardiometabolic, and respirator...

Awarded: NOK 20.6 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Big Data Models and Intelligent tools for Quality of Life monitoring and participatory empowerment of head and neck cancer survivors

Head and neck cancer can take away a patient’s “right to feel human,” and its impact on physical appearance, physical functioning, psychological status and general quality of life (QoL) can be devastating. Over the past several decades, the number of patients who survive head and neck cancer (HNC...

Awarded: NOK 3.1 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY

Atrial fibrillation (AF) is an increasingly common arrhythmia in the aging European population. Its prevalence will more than double by the year 2050 affecting 5% of EU women and men aged 65 years. AF carries a high risk of stroke, heart failure, and dementia, which result in a significant loss o...

Awarded: NOK 0.54 mill.

Project Period: 2020-2022

Location: Troms - Romsa - Tromssa

H20-HEALTH-Health, demographic change and wellbeing

Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms

Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms

Awarded: NOK 15.0 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome

Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the interaction between exposome and immune system plays a pivotal role. As prevalence and societal costs of these diseases are rising in the EU, a holistic approa...

Awarded: NOK 13.2 mill.

Project Period: 2020-2024

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Establishment and Exploitation of a European-Latin American Research Consortium towards Eradication of Preventable Gallbladder Cancer

Gallbladder cancer (GBC) is a neglected disease with huge potential for prevention. This project aims at significantly improving the accuracy of risk estimation and early detection of GBC by identifying and adequately considering geographical, environmental, lifestyle, ethnic, gender and molecula...

Awarded: NOK 7.3 mill.

Project Period: 2019-2025

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Up-scaling the global univocal identification of medicines

This innovation action will give a powerful impulse to implementation of ISO IDMP (ID of Medicinal Products) standards in EU Member States drug databases, supporting safe cross-border ePrescription/eDispensation and effective pharmacovigilance. Once EU-interoperable data on medicines taken by pat...

Awarded: NOK 6.1 mill.

Project Period: 2019-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

Awarded: NOK 1.2 mill.

Project Period: 2019-2025

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases

Awarded: NOK 2.3 mill.

Project Period: 2019-2025

Location: Rogaland

H20-HEALTH-Health, demographic change and wellbeing

Smart and Healthy Ageing through People Engaging in Supportive Systems

SHAPES aims to create the first European open Ecosystem enabling the large-scale deployment of a broad range of digital solutions for supporting and extending healthy and independent living for older individuals who are facing permanently or temporarily reduced functionality and capabilities. SHA...

Awarded: NOK 5.0 mill.

Project Period: 2019-2023

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions

Awarded: NOK 2.0 mill.

Project Period: 2019-2026

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

EXpanding Platforms for Efficacious mRNA Therapeutics

The overall objective of EXPERT is to create an off-the-shelf mRNA-delivering nanomedicine platform that is manufactured via a quality-by-design (QbD) approach with precise nanoparticle characterization and specifications that meet the requirements for GMP scaling up and clinical translation. As ...

Awarded: NOK 11.1 mill.

Project Period: 2019-2025

Location: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Parkinson Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. There is an unmet clinical need to treat Parkinson disease with mild cognitive impairment (PD-MCI). There is ample evidence from epidemiological studies as well as (pre)clinical research that Nic...

Awarded: NOK 0.30 mill.

Project Period: 2019-2022

Location: Rogaland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

EU-CEPI Framework Agreement for vaccine development

EU-CEPI Framework Agreement for vaccine development

Awarded: Hidden

Project Period: 2019-2022

Location: Oslo

12345